↓ Skip to main content

Dove Medical Press

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date

Overview of attention for article published in Journal of Hepatocellular Carcinoma, January 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#13 of 234)
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
2 X users
patent
2 patents

Citations

dimensions_citation
59 Dimensions

Readers on

mendeley
79 Mendeley